Emil Frei

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Emil Frei III
Nci-vol-1838-300 Emil Frei.jpg
Born (1924-02-21)February 21, 1924
St. Louis, Missouri
Died April 30, 2013(2013-04-30) (aged 89)
Oak Park, Illinois
Citizenship United States
Institutions National Cancer Institute
MD Anderson Cancer Center
Dana-Farber Cancer Institute
Alma mater Colgate University
Yale School of Medicine
Known for Cancer research
Spouse

Elizabeth Smith (nurse), 1948-1986 (her death)

Adoria Brock, 1987-2009 (her death)
Children 5

Emil "Tom" Frei III (February 21, 1924 – April 30, 2013) was an American physician and oncologist. He was the former director and former physician-in-chief of the Dana-Farber Cancer Institute in Boston, Massachusetts. He was also the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School.[1]

Early life and education[edit]

Frei was born in 1924 in St. Louis.[2] His family owned the stained glass manufacturer Emil Frei & Associates. Frei completed an accelerated pre-med Colgate University in 1944 after only 2 years of study[3] and his medical degree from Yale University in 1948.

Career[edit]

He interned at Firmin Desloge Hospital, now St. Louis University Hospital in St. Louis, MIssouri and served as a physician in the Korean War. He worked at the National Cancer Institute from 1955 to 1965 and the M. D. Anderson Cancer Center from 1965 to 1972; while at M.D. Anderson he was the founding director of the Department of Development Therapeutics, which evolved into the Clinical Research Center. He served as physician-in-chief at the Dana-Farber Institute from 1972 to 1991. He is best known for his work on the treatment of lymphomas and childhood and adult leukemia.[4] His groundbreaking research into then-controversial combination chemotherapy earned him many awards.[3]

He coauthored "Cancer Medicine" with Dr. James F. Holland.

Involvement in Cancer Cooperative Group Research[edit]

Frei was one of the founders of the Acute Leukemia Group B which later evolved into the Cancer and Leukemia Group B (CALGB). He served as the group chair for 16 years, from 1956 to 1963, and again from 1981 to 1990.[5]

Recognition[edit]

In 1972 he received the Lasker-DeBakey Clinical Medical Research Award from the Lasker Foundation "for his outstanding contribution in application of the concept of combination chemotherapy for lymphoma and acute adult leukemia."[6] Other awards included the Jeffrey A. Gottlieb Memorial Award (1978); NIH Distinguished Alumni Award (1990); Fellow, American Academy of Arts and Sciences (1999); Pollin Prize for Pediatric Research (2003); and AARC Lifetime Achievement Award (2004).[7]

Death[edit]

Frei died at his home of Parkinson's Disease in Oak Park, Illinois on April 30, 2013. He was 89.[2]

References[edit]

  1. ^ "Official biography". Dana-Farber Cancer Institute. Archived from the original on 4 March 2016. Retrieved 13 March 2013. 
  2. ^ a b Fox, Margalit (4 May 2013). "Emil Frei III, Who Put Cancer Cures in Reach, Dies at 89". The New York Times. Retrieved 5 May 2013. 
  3. ^ a b http://cancerres.aacrjournals.org/content/73/15/4597
  4. ^ "Emil Frei III". Animals in Research. National Institutes of Health. Archived from the original on 30 October 2011. Retrieved 13 March 2013. 
  5. ^ "History of CALGB". 
  6. ^ "Lasker Award". National Institutes of Health. Retrieved 13 March 2013. 
  7. ^ "Biographical note: Emil Frei, III". Making Cancer History Voices Collection. University of Texas Archival Resources Online. Retrieved 13 March 2013. 

External links[edit]